Search
What are you looking for?
Start main content

Press Releases

Press Releases

https://www.med.cuhk.edu.hk/press-releases/cuhk-study-finds-rising-laryngeal-cancer-rates-among-women-in-some-locations-despite-global-decline
https://www.med.cuhk.edu.hk/press-releases/cuhk-study-finds-rising-laryngeal-cancer-rates-among-women-in-some-locations-despite-global-decline

CUHK study finds rising laryngeal cancer rates among women in some locations, despite global decline

Laryngeal cancer is a rare form of respiratory cancer affecting the larynx and vocal cords. The five-year survival rate in the early stages can be as high as 90%, but drastically drops to about 30% in the later stages. Addressing the current lack of epidemiological information will help healthcare professionals to understand the current disease burden of laryngeal cancer and better rationalise treatment and resource allocation.

 

The Chinese University of Hong Kong (CUHK)’s Faculty of Medicine (CU Medicine) has collaborated with the Association of Pacific Rim Universities (APRU) to analyse the global distribution, risk factors and epidemiological trends of laryngeal cancer. These novel results showed that the incidence of laryngeal cancer is related to different places’ per capita GDP, Human Development Index (HDI), and levels of unhealthy lifestyle habits and exposure to metabolic risk factors. The incidence and mortality rates are generally higher in middle- and high-income countries and regions. Crucially, researchers highlighted that despite the decline in the global incidence of laryngeal cancer over the past decade, both the incidence and mortality rates among women in certain regions have increased. The research team urgently calls for further exploration of the reasons for the increased burden of laryngeal cancer in women. The details of this research have been published in a top international medical journal, the International Journal of Surgery.

 

Laryngeal cancer linked to numerous risk factors, with higher burden in middle- and high-income countries

 

Laryngeal cancer primarily affects individuals aged between 45 and 70, with a significant gender disparity: the ratio of male to female patients is 13:1. Risk factors include smoking and alcohol consumption—in particular, the tar and carcinogens contained in cigarettes can irritate the throat, causing mucosal hyperplasia, which may then develop into leukoplakia and carcinogenesis. Due to global efforts in recent years to encourage smoking reduction and prevent excessive drinking, the overall incidence and mortality rates of laryngeal cancer have been declining, especially among men. However, regional disparities in laryngeal cancer incidence and mortality rates continue to persist due to varying levels of access to medical care.

 

This research sought to estimate the disease burden and distribution of laryngeal cancer around the world, with a focus on identifying high-risk populations. The research team collected cancer incidence data and the prevalence of different laryngeal cancer risk factors via several sources, including the World Health Organization Global Cancer Observatory, and the Cancer Incidence in Five Continents and Global Disease Burden studies. Researchers found that the disease burden caused by laryngeal cancer differs by region, with the Caribbean having the highest incidence and mortality rates globally (see Tables 1 and 2 for detailed data). Laryngeal cancer was associated with smoking, drinking, unhealthy diet, lack of exercise, obesity, hypertension, diabetes and dyslipidemia, with higher incidence and mortality rates observed among people exposed to these risk factors.

 

Table 1 – Top three regions with highest age-standardised incidence of laryngeal cancer

Top three regions with highest incidence of laryngeal cancer

Standardised incidence (per 100,000)(%)

Caribbean

4.0

Central and Eastern Europe

3.6

Southern Europe

2.9

Table 2 –Top three regions with the highest age-standardised death rates from laryngeal cancer

Country

Standardised incidence (per 100,000)(%)

Caribbean

2.1

Central and Eastern Europe

1.9

Central and South Asia

1.7

map
Rise in female laryngeal cancer rates in some regions demands further analysis

 

Although the global incidence rate of laryngeal cancer has been generally declining over the past decade, there are indications of an increase in the incidence among women in certain areas. The Average Annual Percentage Change (AAPC1) in female incidence rates has significantly increased, with Japan, Switzerland and the Czech Republic showing the most notable rises (see Table 3 for detailed data).

 

Table 3 –Top three countries with the highest AAPC from laryngeal cancer

Country

Standardised incidence (per 100,000)(%)

Japan

6.0

Switzerland

5.6

Czech Republic

3.3

 

Dr Huang and Prof Wong

Dr. Jason Huang (left) and Professor Martin Wong

Dr. Jason Junjie Huang, the first author of the study and Research Assistant Professor from The Jockey Club School of Public Health and Primary Care at CU Medicine, stated, “The incidence of laryngeal cancer varies regionally, which may be related to local diagnostic and treatment levels, environmental lifestyles, and policies controlling smoking and alcohol consumption. Our research provides the latest and most comprehensive evidence on the global distribution, risk factors and epidemiological trends of laryngeal cancer. Policymakers in various regions should implement targeted, evidence-based prevention strategies, such as smoking cessation and alcohol control measures, to manage the risk factors.”

 

Professor Martin Chi-sang Wong, the senior corresponding author of the study, Professor of  The Jockey Club School of Public Health and Primary Care at CU Medicine, added, “In recent years, the overall incidence of laryngeal cancer has been declining, but the rising incidence among women in certain areas is concerning. The reasons behind this trend are unclear and may be related to increasing peripheral environmental factors, lifestyle habits and metabolic risk factors. The medical community should further explore the causes of these epidemiological changes to provide important insights for the prevention and treatment of laryngeal cancer.”

This study was conducted in collaboration with Professor Mellissa Withers, Director of the APRU Global Health Program and a faculty member at the Keck School of Medicine within the University of Southern California.

 

Study details can be found at: https://doi.org/10.1097/JS9.0000000000000902

 

1AAPC is a measure of the overall changes in cancer incidence over a specific period. For example, if the incidence AAPC of a certain cancer in a country is five for the past 10 years, it means that the incidence in that country increased by 5% on average each year over the 10-year period.

 

About this collaborative study with APRU


This study is a collaboration with Professor Mellissa Withers, the Director of the APRU Global Health Programme, Keck School of Medicine, University of Southern California. The APRU (https://apru.org/) was established in Los Angeles in 1997 by the presidents of UCLA, Berkeley, Caltech and the University of Southern California. It now has a membership of 60 leading research universities from around the Pacific Rim. CUHK is an important member of APRU, and Professor Martin Chi-sang Wong and Dr Jason Junjie Huang are currently the Co-Chairs of the network’s Non-Communicable Diseases (NCD) Global Health Working Group.

 

 

More Press Releases

CUHK’s study sees small intestinal cancer incidence rising globally and in Hong Kong Higher incidence observed in high-income countries

CUHK’s study sees small intestinal cancer incidence rising globally and in Hong Kong Higher incidence observed in high-income countries

Research
CUHK proves the eHealth App’s Health Management module helps promote  self-management of diabetes

CUHK proves the eHealth App’s Health Management module helps promote self-management of diabetes

Research
CUHK study sees a rising trend in primary brain cancer incidence in younger males in high-income countries

CUHK study sees a rising trend in primary brain cancer incidence in younger males in high-income countries

Research
CUHK’s study sees a rising trend of multiple myeloma incidence,  particularly in older males from high-income countries

CUHK’s study sees a rising trend of multiple myeloma incidence, particularly in older males from high-income countries

Research
Bowel Cancer Will Become Top Cancer in Hong Kong CUHK Introduces Colon Pill Camera to Prevent Bowel Cancer

Bowel Cancer Will Become Top Cancer in Hong Kong CUHK Introduces Colon Pill Camera to Prevent Bowel Cancer

Surgical advancement
Predicting Your Colorectal-polyp Risk with CUHK Colorectal-polyp Prediction Index (CU-CPI)

Predicting Your Colorectal-polyp Risk with CUHK Colorectal-polyp Prediction Index (CU-CPI)

Clinical service
CUHK and HKU lead a study highlighting higher risks of prediabetes and diabetes under chronic PM2.5 exposure

CUHK and HKU lead a study highlighting higher risks of prediabetes and diabetes under chronic PM2.5 exposure

Research
CUHK develops novel molecular classification of cancer-associated fibroblasts across multiple cancers, improving understanding for more targeted treatment

CUHK develops novel molecular classification of cancer-associated fibroblasts across multiple cancers, improving understanding for more targeted treatment

Research
Professor Anthony Chan honoured with the ESMO Lifetime Achievement Award  Global recognition for his leadership and outstanding research in nasopharyngeal cancer

Professor Anthony Chan honoured with the ESMO Lifetime Achievement Award Global recognition for his leadership and outstanding research in nasopharyngeal cancer

Awards and honors
CUHK Phase 1 Clinical Trial Centre celebrates 10th anniversary Centre has completed 150 early-stage studies of novel drugs for cancer, diabetes and more

CUHK Phase 1 Clinical Trial Centre celebrates 10th anniversary Centre has completed 150 early-stage studies of novel drugs for cancer, diabetes and more

Research
CU Medicine’s Assisted Reproductive Technology (ART) Unit preserves the reproductive ability of cancer patients in Hong Kong

CU Medicine’s Assisted Reproductive Technology (ART) Unit preserves the reproductive ability of cancer patients in Hong Kong

Research
CUHK study concludes that plasma EBV DNA screening can detect early asymptomatic nasopharyngeal cancer and reflect the risk of future cancer development

CUHK study concludes that plasma EBV DNA screening can detect early asymptomatic nasopharyngeal cancer and reflect the risk of future cancer development

Research
A randomised placebo-controlled clinical trial by CU Medicine shows that modulation of gut microbiome using oral microencapsulated live bacteria (SIM01) improves long COVID symptoms

A randomised placebo-controlled clinical trial by CU Medicine shows that modulation of gut microbiome using oral microencapsulated live bacteria (SIM01) improves long COVID symptoms

Research
CU Medicine leads new clinical practice guidelines on use of non-invasive biomarkers for colorectal cancer screening with international experts

CU Medicine leads new clinical practice guidelines on use of non-invasive biomarkers for colorectal cancer screening with international experts

Research
CUHK study sees a rising trend of mesothelioma incidence in females and a higher incidence in high-income countries

CUHK study sees a rising trend of mesothelioma incidence in females and a higher incidence in high-income countries

Research
CUHK unlocks the secret of cancer pain  Identifying a new therapeutic key to ending the sorrow

CUHK unlocks the secret of cancer pain Identifying a new therapeutic key to ending the sorrow

Research
CUHK first discovers obese patients with diabetes and fluctuating blood glucose control had a high cancer risk while patients with diabetes treated with a common class of blood pressure lowering drug had a low cancer risk

CUHK first discovers obese patients with diabetes and fluctuating blood glucose control had a high cancer risk while patients with diabetes treated with a common class of blood pressure lowering drug had a low cancer risk

Research
CUHK finds the largest rise in incidence of Hodgkin lymphoma in Asia Rising trend of male incidence means Hong Kong tops the world

CUHK finds the largest rise in incidence of Hodgkin lymphoma in Asia Rising trend of male incidence means Hong Kong tops the world

Research
CU Medicine finds Eastern Asia’s lung cancer incidence and mortality highest in the world

CU Medicine finds Eastern Asia’s lung cancer incidence and mortality highest in the world

Research
CUHK dissects lung carcinoma at single-cell resolution uncovering a new mechanism for tumour formation

CUHK dissects lung carcinoma at single-cell resolution uncovering a new mechanism for tumour formation

Research
CU Medicine Survey Shows Only 25% of Unvaccinated People Intend to Get Inoculated in the Coming Six Months “Multiple Incentives” are Urgently Needed

CU Medicine Survey Shows Only 25% of Unvaccinated People Intend to Get Inoculated in the Coming Six Months “Multiple Incentives” are Urgently Needed

Research
CUHK Study Finds Half of Childhood Cancer Survivors Used Complementary and Alternative Medicine

CUHK Study Finds Half of Childhood Cancer Survivors Used Complementary and Alternative Medicine

Research
CU Medicine Estimates 20,000 COVID-19 Hidden Infections in Hong Kong  All Vaccinated Persons in HK Developed Neutralising Antibody After Two Doses  Urgent Call for the Largely Unprotected Population to Get Vaccinated

CU Medicine Estimates 20,000 COVID-19 Hidden Infections in Hong Kong All Vaccinated Persons in HK Developed Neutralising Antibody After Two Doses Urgent Call for the Largely Unprotected Population to Get Vaccinated

Research
CU Medicine Survey Shows Government Recommendation as the Strongest Driver for COVID-19 Vaccine Acceptance

CU Medicine Survey Shows Government Recommendation as the Strongest Driver for COVID-19 Vaccine Acceptance

Research
CU Medicine Study Proves Pocket-size Mobile Echocardiographic Screening Device Effective in Detecting Thoracic Aortic Aneurysm

CU Medicine Study Proves Pocket-size Mobile Echocardiographic Screening Device Effective in Detecting Thoracic Aortic Aneurysm

Research
CU Medicine Studies Highlight Smoking as a Contributing Factor for Bladder Cancer and  Develop an International Collaborative Consensus on En Bloc Resection to Treat the Disease

CU Medicine Studies Highlight Smoking as a Contributing Factor for Bladder Cancer and Develop an International Collaborative Consensus on En Bloc Resection to Treat the Disease

Research
CU Medicine Finds An Increasing Global Trend on Pancreatic Cancer among Female and Younger Individuals

CU Medicine Finds An Increasing Global Trend on Pancreatic Cancer among Female and Younger Individuals

Research
Insights into B-cells and GPR18 Gene Expression by CU Medicine team  Improve Prediction of Survival in Multiple Cancer Types

Insights into B-cells and GPR18 Gene Expression by CU Medicine team Improve Prediction of Survival in Multiple Cancer Types

Research
CU Medicine Team Discovers a Novel Prognostic Biomarker for a Doubled Survival in Head and Neck Cancer

CU Medicine Team Discovers a Novel Prognostic Biomarker for a Doubled Survival in Head and Neck Cancer

Research
CUHK in collaboration with West China School of Medicine co-Led World’s First-in-human Clinical Trial using CRISPR technology for lung cancer Confirmed gene-edited T-Cell Therapy is Safe and Feasible in Treatment of Advanced NSCLC

CUHK in collaboration with West China School of Medicine co-Led World’s First-in-human Clinical Trial using CRISPR technology for lung cancer Confirmed gene-edited T-Cell Therapy is Safe and Feasible in Treatment of Advanced NSCLC

Research
CU Medicine Recruits 3,000 Persons to Investigate Hidden Infection and Break the Obstacles in Containing COVID-19 in Hong Kong

CU Medicine Recruits 3,000 Persons to Investigate Hidden Infection and Break the Obstacles in Containing COVID-19 in Hong Kong

Research
CUHK to Commence the Next-Generation Clinical Trials of CAR-T Cell Therapy for Haematological Malignancy

CUHK to Commence the Next-Generation Clinical Trials of CAR-T Cell Therapy for Haematological Malignancy

Research
CUHK Successfully Conducts Asia-Pacific’s First Hybrid Operating Room Non-invasive Bronchoscopic Microwave Ablation to Treat Lung Cancer

CUHK Successfully Conducts Asia-Pacific’s First Hybrid Operating Room Non-invasive Bronchoscopic Microwave Ablation to Treat Lung Cancer

Surgical advancement
Hong Kong’s waters benefit health and wellbeing

Hong Kong’s waters benefit health and wellbeing

Research
李嘉誠基金會啟動《愛能助》兒童癌症項目 資助兒童罕見癌症 (Chinese version only)

李嘉誠基金會啟動《愛能助》兒童癌症項目 資助兒童罕見癌症 (Chinese version only)

Donation
Professor Tony MOK Honoured with the ESMO Lifetime Achievement Award Recognising His Global Leadership in Defining Lung Cancer Treatment Standard

Professor Tony MOK Honoured with the ESMO Lifetime Achievement Award Recognising His Global Leadership in Defining Lung Cancer Treatment Standard

Awards and honors
CUHK Receives an International Cancer Care Team Award Nominated by Patients

CUHK Receives an International Cancer Care Team Award Nominated by Patients

Awards and honors
CUHK Launches Multi-Cancer Prevention Programme Providing Free Screening to 10,000 HK Residents to Study Links with Obesity

CUHK Launches Multi-Cancer Prevention Programme Providing Free Screening to 10,000 HK Residents to Study Links with Obesity

Health Campaign
CUHK-led Global Study Sees Improvement in Overall Survival in Patients with Advanced Lung Cancer

CUHK-led Global Study Sees Improvement in Overall Survival in Patients with Advanced Lung Cancer

Research
CUHK Study Sees Increasing Global Incidence of Colorectal Cancer Among Younger People

CUHK Study Sees Increasing Global Incidence of Colorectal Cancer Among Younger People

Research
CUHK Pioneers Early Lung Cancer Treatment with Hybrid Operating Room Image Guided Electromagnetic Navigation Bronchoscopy

CUHK Pioneers Early Lung Cancer Treatment with Hybrid Operating Room Image Guided Electromagnetic Navigation Bronchoscopy

Surgical advancement
A CUHK-led International Study Demonstrates Immune-checkpoint Inhibitor Is Effective in Patients with Advanced Nasopharyngeal Cancer

A CUHK-led International Study Demonstrates Immune-checkpoint Inhibitor Is Effective in Patients with Advanced Nasopharyngeal Cancer

Research
CUHK Study Proves Ablative Chemoembolization Doubles the Progression-Free Survival for Liver Cancer Patients

CUHK Study Proves Ablative Chemoembolization Doubles the Progression-Free Survival for Liver Cancer Patients

Research
CUHK Research Receives Recognitions by Top Medical Journals

CUHK Research Receives Recognitions by Top Medical Journals

Awards and honors
CUHK-HKU Study on Multi-gene Mutation-Drug Matching for Recurrent Ovarian Cancer Patients Providing Free Pharmacogenomic Analysis for 100 Patients in Hong Kong

CUHK-HKU Study on Multi-gene Mutation-Drug Matching for Recurrent Ovarian Cancer Patients Providing Free Pharmacogenomic Analysis for 100 Patients in Hong Kong

Research
CUHK Completes a 20,000-person Plasma DNA Screening Study of Nasopharyngeal Cancer, and Finds a Dramatic Shift to Early Stage Cancers

CUHK Completes a 20,000-person Plasma DNA Screening Study of Nasopharyngeal Cancer, and Finds a Dramatic Shift to Early Stage Cancers

Research
CUHK-led Research Confirms Novel Targeted Therapy Doubles the Effectiveness of Current Standard Treatment for ALK-Positive Lung Cancer

CUHK-led Research Confirms Novel Targeted Therapy Doubles the Effectiveness of Current Standard Treatment for ALK-Positive Lung Cancer

Research
CUHK Uncovers Novel Immune Escape Mechanism of Cancer Opening Up New Direction for Cancer Immunotherapy

CUHK Uncovers Novel Immune Escape Mechanism of Cancer Opening Up New Direction for Cancer Immunotherapy

Research
CUHK Unravels the Whole Genome of Nasopharyngeal Cancer A Great Leap Forward in Personalized Medicine Development

CUHK Unravels the Whole Genome of Nasopharyngeal Cancer A Great Leap Forward in Personalized Medicine Development

Research
CUHK Research Shows 1 in 5 Throat Cancer Patients in HK is HPV infected

CUHK Research Shows 1 in 5 Throat Cancer Patients in HK is HPV infected

Research
CUHK Research by Medical Undergraduates Reveals Poor Medication Adherence Among Hypertensive Patients in Hong Kong

CUHK Research by Medical Undergraduates Reveals Poor Medication Adherence Among Hypertensive Patients in Hong Kong

Research
The 7th Palliative Care Symposium for Health Care Workers in Chinese Population: ‘Palliative Care in the Community’

The 7th Palliative Care Symposium for Health Care Workers in Chinese Population: ‘Palliative Care in the Community’

Symposium
CUHK Welcomes Government’s Proposal on Bowel Cancer Screening Territory-wide Bowel Cancer Screening Programme Shows 14% of Participants Diagnosed with Bowel Cancer or Pre-cancer

CUHK Welcomes Government’s Proposal on Bowel Cancer Screening Territory-wide Bowel Cancer Screening Programme Shows 14% of Participants Diagnosed with Bowel Cancer or Pre-cancer

Research
CUHK Succeeded in Animal Study and Clinical Case of Percutaneous Nanoknife New Breakthrough in Cancer Treatment

CUHK Succeeded in Animal Study and Clinical Case of Percutaneous Nanoknife New Breakthrough in Cancer Treatment

Research
CUHK Discovers Innovative ‘Flow Diverters’ (Pipeline) as Effective Treatment for Cerebral Aneurysms in Asia’s First Clinical Study in Collaboration with Seven Medical Centres

CUHK Discovers Innovative ‘Flow Diverters’ (Pipeline) as Effective Treatment for Cerebral Aneurysms in Asia’s First Clinical Study in Collaboration with Seven Medical Centres

Research
CUHK and HKU Host the 5th Annual Palliative Care Symposium for Health Care Workers in Chinese Population

CUHK and HKU Host the 5th Annual Palliative Care Symposium for Health Care Workers in Chinese Population

Symposium
CUHK Pioneers Innovative Computer Assisted Tumor Surgery for Bone Cancer Patients

CUHK Pioneers Innovative Computer Assisted Tumor Surgery for Bone Cancer Patients

Surgical advancement
CUHK Discovers Up to 30% of Asymptomatic Subjects in Hong Kong Suffered from Pre-cancerous Bowel Tumors

CUHK Discovers Up to 30% of Asymptomatic Subjects in Hong Kong Suffered from Pre-cancerous Bowel Tumors

Research
The Chinese University of Hong Kong Nethersole School of Nursing hosts the Fifth Pan-Pacific Nursing Conference and Seventh Nursing Symposium on Cancer Care

The Chinese University of Hong Kong Nethersole School of Nursing hosts the Fifth Pan-Pacific Nursing Conference and Seventh Nursing Symposium on Cancer Care

Symposium

Our Expert List

Many experts under the Faculty of Medicine are available for media interview.
Please click here for the expert list or contact us.